Search - tctmd.com

Displaying 121 - 140 of 14831

Sort: Relevancy | Date

News Conference News ESC 2025

Olezarsen Brings Moderately High Triglycerides Under Control: ESSENCE-TIMI 73b

Caitlin E. Cox

August 31, 2025

News Conference News ESC 2025

No Benefit to Routine CT Angiography After Left Main PCI: PULSE

Michael O'Riordan

August 31, 2025

Presentation ESC 2025

BETAMI-DANBLOCK: Randomized Discontinuation of Beta-blockers After Myocardial Infarction in Patients Without Heart Failure

Presenter: Eva Prescott, Dan Atar

August 30, 2025

Presentation ESC 2025

Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction: REBOOT

Presenter: Borja Ibanez

August 30, 2025

Presentation ESC 2025

AQUATIC: Assessment of Quitting versus Using Aspirin Therapy In patients with stabilized Coronary artery disease after stenting who require long-term oral anticoagulation

Presenter: Martine Gilard

August 30, 2025

Presentation ESC 2025

PercutaNEOus Coronary Intervention Followed by Monotherapy INstead of Dual Antiplatelet Therapy in the SETting of Acute Coronary Syndromes: The NEO-MINDSET trial

Presenter: Pedro A. Lemos

August 30, 2025

News Conference News ESC 2025

Mixed Results for Beta-blockers in Post-MI Patients With Preserved EF

Michael O'Riordan

August 30, 2025

News Opinion Editor's Corner

TCTMD's Top 10 Most Popular Stories for August 2025

Caitlin E. Cox

August 28, 2025

News Daily News

Another Issue Shelves Some Impella Blood Pump Controllers: FDA

Todd Neale

August 27, 2025

News Daily News

Evolocumab Gains Expanded Indication for Primary Prevention

Michael O'Riordan

August 26, 2025

News Opinion Editor's Corner ESC 2025

What’s Going to Be Hot at ESC Congress 2025?

Michael O'Riordan

August 25, 2025

News Opinion CV Team Dispatch

August 2025 Dispatch for the CV Team

L.A. McKeown

August 22, 2025

News Daily News

DAPT De-escalation Success Varies by Sex: Meta-analysis

Yael L. Maxwell

August 21, 2025

News Daily News

For Monotherapy, P2Y12 Inhibitor Bests Aspirin After PCI for ACS: Meta-analysis

Yael L. Maxwell

August 14, 2025

$Coronary Sinus Reducer ‘Promising’ for Refractory Angina: Meta-analysis$

News Daily News

Coronary Sinus Reducer ‘Promising’ for Refractory Angina: Meta-analysis

Todd Neale

August 13, 2025

News Daily News

Coronary DCB Works Well in Multilayer In-Stent Restenosis: AGENT IDE Subanalysis

L.A. McKeown

August 12, 2025

With MISSON Act, Veterans Get More Convenient but Potentially Worse CV Care

News Daily News

With MISSION Act, Veterans Get More Convenient but Potentially Worse CV Care

Yael L. Maxwell

August 08, 2025

News Daily News

Inclisiran Gains Indication as Stand-alone Therapy to Reduce LDL Cholesterol

Michael O'Riordan

August 06, 2025

News Daily News

Newer Radiation Shielding System Protects More Than Just Operators

L.A. McKeown

August 04, 2025

News Daily News

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

Michael O'Riordan

August 01, 2025

Advertisement

Olezarsen Brings Moderately High Triglycerides Under Control: ESSENCE-TIMI 73b

No Benefit to Routine CT Angiography After Left Main PCI: PULSE

BETAMI-DANBLOCK: Randomized Discontinuation of Beta-blockers After Myocardial Infarction in Patients Without Heart Failure

Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction: REBOOT

AQUATIC: Assessment of Quitting versus Using Aspirin Therapy In patients with stabilized Coronary artery disease after stenting who require long-term oral anticoagulation

PercutaNEOus Coronary Intervention Followed by Monotherapy INstead of Dual Antiplatelet Therapy in the SETting of Acute Coronary Syndromes: The NEO-MINDSET trial

Mixed Results for Beta-blockers in Post-MI Patients With Preserved EF

TCTMD's Top 10 Most Popular Stories for August 2025

Another Issue Shelves Some Impella Blood Pump Controllers: FDA

Evolocumab Gains Expanded Indication for Primary Prevention

What’s Going to Be Hot at ESC Congress 2025?

August 2025 Dispatch for the CV Team

DAPT De-escalation Success Varies by Sex: Meta-analysis

For Monotherapy, P2Y12 Inhibitor Bests Aspirin After PCI for ACS: Meta-analysis

Coronary Sinus Reducer ‘Promising’ for Refractory Angina: Meta-analysis

Coronary DCB Works Well in Multilayer In-Stent Restenosis: AGENT IDE Subanalysis

With MISSION Act, Veterans Get More Convenient but Potentially Worse CV Care

Inclisiran Gains Indication as Stand-alone Therapy to Reduce LDL Cholesterol

Newer Radiation Shielding System Protects More Than Just Operators

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content